Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Guillem García-Llorens"'
Autor:
Marta Moreno-Torres, Guillem García-Llorens, Erika Moro, Rebeca Méndez, Guillermo Quintás, José Vicente Castell
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract REACH (Registration, Evaluation, Authorization and Restriction of Chemicals) is a global strategy and regulation policy of the EU that aims to improve the protection of human health and the environment through the better and earlier identifi
Externí odkaz:
https://doaj.org/article/4dee4ab973534549828fbc123ace29d7
Autor:
Marta Moreno-Torres, Manoj Kumar, Guillem García-Llorens, Guillermo Quintás, Tine Tricot, Ruben Boon, Laia Tolosa, Burak Toprakhisar, Francois Chesnais, Catherine Verfaillie, José V. Castell
Publikováno v:
Journal of Proteome Research
Typical protocols to differentiate induced pluripotent stem cells (iPSCs) from hepatocyte-like cells (HLCs) imply complex strategies that include transfection with key hepatic transcription factors and the addition to culture media of nutrients, grow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a70c11f37b33312592da01bf81a1e317
https://pubmed.ncbi.nlm.nih.gov/34982937
https://pubmed.ncbi.nlm.nih.gov/34982937
Autor:
Guillem Garcia-Llorens, Teresa Martínez-Sena, Eugenia Pareja, Laia Tolosa, José V. Castell, Roque Bort
Publikováno v:
Stem Cell Research & Therapy, Vol 14, Iss 1, Pp 1-19 (2023)
Abstract Background High-throughput pharmaco-toxicological testing frequently relies on the use of established liver-derived cell lines, such as HepG2 cells. However, these cells often display limited hepatic phenotype and features of neoplastic tran
Externí odkaz:
https://doaj.org/article/62a962e9da144657bf30508219281295
Autor:
Ernesto López-Pascual, Ivan Rienda, Judith Perez-Rojas, Anna Rapisarda, Guillem Garcia-Llorens, Ramiro Jover, José V. Castell
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 10, p 5203 (2024)
Drug induced fatty liver disease (DIFLD) is a form of drug-induced liver injury (DILI), which can also be included in the more general metabolic dysfunction-associated steatotic liver disease (MASLD), which specifically refers to the accumulation of
Externí odkaz:
https://doaj.org/article/f86504396c4649ed9255bfce37a424bc
Autor:
Ramon Santamaria, Maria Ballester, Guillem Garcia-Llorens, Francisco Martinez, Marina Blazquez, Carmen Ribes-Koninckx, Jose V. Castell, Torsten Wuestefeld, Roque Bort
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Autologous cell replacement therapy for inherited metabolic disorders requires the correction of the underlying genetic mutation in patient’s cells. An unexplored alternative for females affected from X-linked diseases is the clonal select
Externí odkaz:
https://doaj.org/article/600b73e1671842128c57be6cc7e8f4d4